Mar 30, 2013 | Stocks
Anthera Pharmaceuticals (NASDAQ:ANTH) is a bio-pharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders. Recently they have been performing clinical trials using the drug...
